Skip to main content
Howard Gross, MD, Oncology, Dayton, OH

Howard M Gross MD


Hematologist in Dayton, Ohio. Affiliated with multiple hospitals in the Good Samaritan Hospital and Good Samaritan Hospital and Health Center

Join to view full profile
  • 8881 N Main StDayton, OH 45415

  • Phone+1 937-293-1622

  • Fax+1 937-245-6308

Dr. Gross is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Howard Gross is an oncologist based in Dayton, OH, who completed his fellowship in Hematology and Medical Oncology at the University of Cincinnati Medical Center. He has residency training in Internal Medicine from Christ Hospital. Dr. Gross has expertise in cold agglutinin disease and cold autoimmune hemolytic anemia. His research contributions include publications on tumor regression in rectal adenocarcinoma, cancer-related fatigue, and treatments related to breast cancer, with several studies being widely cited. Additionally, he has been involved in diverse clinical trials focused on lung and colorectal cancer, among other areas. In recognition of his work, Dr. Gross received the CMS Meaningful Use Stage 1 Certification in 2012-2013.

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1980
  • Christ Hospital
    Christ HospitalResidency, Internal Medicine, 1976 - 1979
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1976

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1977 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Dayton Clinical Oncology ProgramDAYTON CLINICAL ONCOLOGY PROGRAM2014–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: